Increased Expression of DNA2 Was Linked to Poor Prognosis in Breast Cancer

Yingyan Han1, Zeyu Zhang1, Zhi Wang1

  • 1Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Disease Markers
|February 12, 2021
PubMed

Insights

Elevated DNA2 nuclease expression correlates with poor breast cancer prognosis and promotes tumor growth. Silencing DNA2 inhibits cancer cell proliferation, identifying DNA2 as a potential diagnostic and prognostic biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Homologous recombination (HR) is crucial for breast cancer cell survival.
  • DNA2 nuclease functions in parallel with HR in DNA double-strand break (DSB) repair.

Purpose of the Study:

  • To investigate the clinical attributes of DNA2 in breast cancer.
  • To determine the role of DNA2 in breast cancer cell growth and progression.

Main Methods:

  • Analysis of large breast cancer datasets (cBioportal, bc-GenExMiner).
  • Immunohistochemical staining of breast cancer tissues.
  • Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO), and KEGG pathway analyses.
  • In vitro cell growth assays and in vivo tumor suppression studies.

Main Results:

  • Elevated DNA2 expression is linked to poor breast cancer prognosis.
  • DNA2 expression is increased in ER-negative, PR-negative, HER2-positive, and high-grade breast cancers.
  • DNA2 is enriched in cell cycle and DNA replication pathways.
  • Silencing DNA2 inhibits breast cancer cell growth and tumor progression.

Conclusions:

  • DNA2 is a potential prognostic biomarker for breast cancer.
  • DNA2 plays a significant role in breast cancer progression.
  • Further preclinical and clinical investigations of DNA2 are warranted.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K